Zhejiang Gongdong Medical Technology Co Ltd (605369) - Total Assets
Based on the latest financial reports, Zhejiang Gongdong Medical Technology Co Ltd (605369) holds total assets worth CN¥2.13 Billion CNY (≈ $311.26 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Zhejiang Gongdong Medical Technology Co book value and equity for net asset value and shareholders' equity analysis.
Zhejiang Gongdong Medical Technology Co Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Zhejiang Gongdong Medical Technology Co Ltd's total assets have evolved over time, based on quarterly financial data.
Zhejiang Gongdong Medical Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Zhejiang Gongdong Medical Technology Co Ltd's total assets of CN¥2.13 Billion consist of 44.3% current assets and 55.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.5% |
| Accounts Receivable | CN¥265.00 Million | 13.6% |
| Inventory | CN¥144.33 Million | 7.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥155.40 Million | 8.0% |
| Goodwill | CN¥200.41 Million | 10.3% |
Asset Composition Trend (2016–2024)
This chart illustrates how Zhejiang Gongdong Medical Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 605369 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Gongdong Medical Technology Co Ltd's current assets represent 44.3% of total assets in 2024, a decrease from 67.8% in 2016.
- Cash Position: Cash and equivalents constituted 15.5% of total assets in 2024, down from 18.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 11.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 13.6% of total assets.
Zhejiang Gongdong Medical Technology Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Gongdong Medical Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcon AG
SW:ALC
|
Switzerland | CHF31.53 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
USA | $32.49 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
Zhejiang Gongdong Medical Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.08 | 3.40 | 6.41 |
| Quick Ratio | 2.65 | 3.00 | 6.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥744.27 Million | CN¥653.42 Million | CN¥884.05 Million |
Zhejiang Gongdong Medical Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Gongdong Medical Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.43 |
| Latest Market Cap to Assets Ratio | 0.33 |
| Asset Growth Rate (YoY) | 3.9% |
| Total Assets | CN¥1.95 Billion |
| Market Capitalization | $635.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Gongdong Medical Technology Co Ltd's assets below their book value (0.33x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang Gongdong Medical Technology Co Ltd's assets grew by 3.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang Gongdong Medical Technology Co Ltd (2016–2024)
The table below shows the annual total assets of Zhejiang Gongdong Medical Technology Co Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.95 Billion ≈ $285.54 Million |
+3.92% |
| 2023-12-31 | CN¥1.88 Billion ≈ $274.76 Million |
+0.55% |
| 2022-12-31 | CN¥1.87 Billion ≈ $273.27 Million |
+10.51% |
| 2021-12-31 | CN¥1.69 Billion ≈ $247.29 Million |
+22.84% |
| 2020-12-31 | CN¥1.38 Billion ≈ $201.30 Million |
+156.64% |
| 2019-12-31 | CN¥536.04 Million ≈ $78.44 Million |
+15.44% |
| 2018-12-31 | CN¥464.35 Million ≈ $67.95 Million |
+41.27% |
| 2017-12-31 | CN¥328.69 Million ≈ $48.10 Million |
-6.61% |
| 2016-12-31 | CN¥351.98 Million ≈ $51.51 Million |
-- |
About Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transf… Read more